K8콢

ԴñͼƬ ߣ 

Լҽ ҵнQQάС150 ;־ʵҰ˼־ е ʵ ҲǸ˽лһַ ŵ Ұӣ

150 ֪Ӱ

꿴 QQάС150 ʵ էΪʲر³Ĵ־ ʵԿǸֽл췽˻ л ͺ һҪʲرʽ150 ֪Һʱ𳤽 ݻイ150 еǡҼҼʮ ˼ǽ꽲ǁ

Ҵȥ浴 ͼֻɨ ǿֱӡСáҿžЦ ǽɨȻйҽ ˵ִ־ʵʲر罻ġ淨ҿ  ǵļ ̫

ִ־ ʵԼġ

꿴 ˽л ʵҰǰǸ л ȥ� ȱ ʳ ġСáҪάɨɨȥ 佲㵱 ȱ˸֡šζˇ

꽲һţڸݽлζ ́Ҫֻ ȥȱߵIJ�    Ǹݵζ 꽲ǁ

ά롱л ݵġ⡱ɶϵ

ά ʵҹ꽲 ԰Ѷά뿴һִġ⡱ǰǸȱ߽־ ¥¥¡β ˶Ϥ Ȼɢ ֶͨά밡 ֡Сáķ ǰѽлϰȥ

л Ҫ̫꽲άС150 ҿǰǸ˽ҼҼʮ ɶ־ ׾ͺÇҪȥ ŪŪ 꽲ǁ


ͼƬ

ܻʇ 150ʲرҹ꽲 ֿܾ˽лĽ æ  ͺ 꽲ǁ

ͼƬ

ǩ#ݽл #ά罻 # #߽ #ϸζ

51һƷ�̳

115 2025ҵ100δҫ ֳɵǰ

Ʒ2020

ձĿг սƷ 籦ΡϷձԽԽԺгٰ쿨ƶսTCGĿг

ҰĵطЩ

9. Ahn MJ,?et al.?Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.?N Engl J Med.?2023;389(22):2063-2075.

վͼ